Discussion
In this retrospective study of middle-aged patients with proximal hamstring avulsions, we found no clinically relevant differences in the outcomes between surgically and non-surgically treated patients 4 years after injury. Our study will increase the number of non-surgically treated patients reported in the literature by a third (n=14). In the latest review of 24 studies and 795 proximal hamstring avulsions, the non-surgical group consisted of only 28 individuals.3
Together with Shambaugh,2 this is the first study comparing patient-reported outcomes after surgical and non-surgical treatment of total proximal hamstring avulsions. There are to date no level 1 or 2 evidence studies presented on method of treatment for this injury, nor are there any large studies comparing the treatment allocations.
Strengths
The two key strengths of this study are that the follow-up is performed using a validated questionnaire, the LEFS, and only 5 of 52 subjects who were assessed as eligible were lost to follow-up. Previous publications found a significant correlation between return to activity, hamstring muscle strength and the single-leg hop test.7 This indicates that LEFS is a validated patient-reported outcome measure and an indicator of the objective function for patients treated for proximal hamstring avulsions. It is notable that the LEFS scores in our study match the LEFS scores in previous studies both for surgically7 10 11 and non-surgically1 2 treated cohorts. In addition to this, we also assessed treatment outcomes quantitatively with patient-reported length of physical activity at follow-up.
Limitations
The most obvious limitation of this retrospective study is that there is bias by indication; the surgeon allocated the patient to the treatment arm at baseline before the study was initiated. This is highlighted by the significant difference between the cohorts with 85% in the surgical treated group having complete proximal hamstring avulsion with at least 2 cm retraction compared with 50% in the non surgical treated group. Since there is no published evidence-based treatment algorithm in the literature indicating on how to treat patients with proximal hamstring avulsion, the treatment decision was based on the orthopaedic surgeon’s experience and local guidelines. The strongest indicators for surgery were MRI finding (Wood type 5 with the tendons avulsed more than 2 cm from the ischial tuberosity), clinical findings and a healthy and active patient. We found a difference at baseline in MRI findings, as there were more patients in the surgically treated group with an MRI result with the tendons avulsed ≥2 cm from the ischial tuberosity than in the non-surgically treated group. This indicates a bias by indication in terms of severity of injury. Thus, cases with a more significant injury and higher activity level were more likely to receive surgical treatment. However, previous published studies also have this problem and are generally case series of surgical treatment.
In addition, there were more females in the non-surgical group and more males allocated to surgical treatment.
LEFS can be a non-specific instrument in patients suffering from a proximal hamstring avulsion. There are studies indicating a risk of the ceiling effect in LEFS.5 12 However, studies have also shown the opposite, recently a systematic review concluded the good reliability, validity and responsiveness of LEFS scores for assessing functional outcomes in patients with various lower musculoskeletal disorders.2 6
The possibility of the ceiling effect was one reason we chose to add several questions from the PHIQ. We found that both groups complain of numbness in their injured leg and that patients in both groups continued to take painkillers for their injured leg.
In the surgical-treated group, patients were training twice as much as in the non-surgical-treated group at our follow-up. As we do not know the physical activity level prior to the injury, it cannot be concluded that there is no difference in physical activity level between the surgically and non-surgically groups.
Interpretation
Considering that this study was performed in a public hospital setting and most of the patients are active middle-aged non-elite athletes, our primary hypothesis was that there would be no differences in LEFS between the two groups at follow-up. The surgical cohort demonstrated a higher severity of injury, with the vast majority of them having complete avulsions with greater than 2 cm of retraction. At t follow-up the surgical cohort were doing physical activity 2.5 hours more than the non-surgical treated cohort. We are aware that this might be a bias by indication. However, we did not find any difference in our primary outcome, LEFS, for surgically treated and non-surgically treated patients. Because the patients in the non-surgical treatment group did not follow any specific physiotherapy protocol, although many physiotherapists in the Stockholm area use the Askling protocol for this injury, we do not know the extent of physiotherapy in this treatment arm. We also do not know if these patients were followed up or if they were left to train by themselves. The non-surgically treated group may thus have scored a higher LEFS result if a comprehensive physiotherapy protocol had been used. Many previous studies describe good results after surgical treatment of proximal hamstring avulsion,13–15 but the problem with many of these studies is that heir instruments are not validated and standardised and that they all lack a control group.
Comparing the results of the validated LEFS in the non-surgically treated cohort of Hofmann et al1 and a surgically treated cohort,7 the scores are similar in both cohorts. The non-surgically treated cohort had 70.2 out of a maximum of 80, and the surgically treated cohort was slightly higher with a mean of 71 out of 80, results that are remarkably consistent with our study. Shambaugh et al2 included 25 patients, with 11 patients in the non-surgical group with a LEFS score of 68.5 (±7.9) and 14 patients in the surgical group with a mean score of 74.7 (±5.4). Notably, the surgically treated patients were, on average, almost 9 years younger (47 vs 55.7 years) in this study.1 2 The LEFS score is also similar to other studies using this validated score with Chahal et al11 reporting LEFS of 75 (±7.8) and Cohen et al10 and Skaara et al7 reporting 75 and 71, respectively, for their patients who underwent surgical treatment. However, all studies have the same problem of bias by indication as with our study.
In the systemic review by van der Made et al,12 the rate of satisfaction with surgery was 88%–100%. Strength ranged in nine studies from 78% to 101% of the uninjured side. From this, most people would be convinced of the benefits of surgery. Interestingly, pain was not uncommon and was reported by 8%–61% of the patients.12 Bodendorfer et al3 summarised the complication rate for the surgically treated patients as high as a 23.7%. The complications described were 2%–3% rerupture, reoperation and infections, 5%–8% incisional numbness and neurological symptoms and 0.68% Venous Tromboembolism (VTE)/Pulmonary Embolism (PE). This indicates surgery is reasonable option for the properly indicated patient, but it is not without risk.
Generalisability
We believe that our results apply to the middle-aged population that we retrospectively reviewed. Retrospective studies are weakened by bias, which likely occurred in this study given the disparity in injury characteristics of the surgical-treated and non-surgical-treated cohorts.